Integrative Pancreatic Intervention Therapy

Maoquan Li is Professor in the Department of Interventional and Vascular Therapy at Shanghai Tenth People’s Hospital at Tongji University. He specializes in interventional radiology. He was the first interventional radiologist in China to conduct interventional treatment of gastric cancer, adrenal tumors, embolization of uterine fibroids, rheological thrombolytic therapy, interventional comprehensive therapy for diabetic vascular disease, interventional comprehensive treatment for chronic thrombus, and the molecular targeted therapy of aesthetic liver cancer. He is a leader in the field. Ligong Lu is Chief Physician, doctoral tutor, and Dean of Zhuhai Hospital, affiliated with Tongji University. He is deputy director of the Institute of Interventional Vascular Research, and Director of the Zhuhai Intervention Centre, and the Zhuhai Precision Medical Treatment Centre. He is a doctoral tutor at Jinan University, Southern Medical University, and Guangdong Provincial Institute of Cardiovascular Disease, as well as a Professor at Macao University. He has been a senior visiting scholar at the Wayne State University Detroit Medical Center. His research focuses on basic and clinical interventional radiology, liver cancer, and malignancies. Yueyong Xiao is Deputy Director of Radiology at Shanghai Military Hospital. He is Chief Physician, and a doctoral tutor, as well as an executive member of the International Refrigeration Association, and President of the Asian Frozen Society. His work in imaging diagnosis and interventional therapy spans 30 years. He carries out CT and MRI guided minimal invasive surgery. He has been a senior visiting scholar at Harvard Medical College, specializing in CT, and MRI-guided interventional therapy. Deliang Fu is the Director of Pancreatic Surgery at Huashan hospital, affiliated with Fudan University in China, and the Director of the Pancreatic Cancer Treatment Center at Fudan University. He is also deputy director of the Institute of Pancreatic Diseases, also at Fudan University, and vice-chairman of the Pancreas Division of the Shanghai Medical Association, as well as a doctoral tutor. He has published widely in the field, both research papers and book chapters, and has led a number of National Natural Science Foundation and Ministry of Health research projects. Haijun Zhang is Director of the National Engineering Laboratory of Biomedical Material Modification Technology, and deputy director of the Institute of Interventional Vascular Research, at Tongji University in China. He is also Director of the strategic alliance for the medical material modification industry. He focuses on biomedical material modification, including in medical material engineering, medical engineering, and transformational medicine.

• Part One Basics and transformation research of pancreatic diseases1. Anatomy and physiology of pancreas 2. Epidemiology, pathological anatomy and pathophysiology of pancreatic diseases3. Clinical laboratory and imaging diagnosis of pancreatic diseases4. Medical therapy of pancreatic diseases5. Surgical treatment of pancreatic diseases6. Emergency and critical care medicine of pancreatic diseases7. Transformation and application advances of pancreatic diseasesPart Two Interventional therapy for benign pancreatic disease8. Clinical interventional therapy for pancreatitis9. Clinical interventional therapy for pancreatic cyst10. Clinical interventional therapy for pancreatic paracrisisPart Three Interventional therapy for malignant pancreatic diseases11. Arterial infusion and arterial chemoembolization therapy for pancreatic cancer12. Radioactive particles implantation for pancreatic cancer 13. Radiofrequency and microwave ablation for pancreatic cancer14. Nano-knife for pancreatic cancer15. HIFU for pancreatic cancerPart Four Interventional Therapy for pancreatic cancer-related lesions16. Minimally Invasive Interventional treatment for Pancreatic carcinoma induced obstructive jaundice 17. Minimally Invasive Interventional treatment for Pancreatic carcinoma induced Intestinal Obstruction 18. Minimally Invasive Interventional treatment for Pancreatic carcinoma induced intractable painPart Five Stem cell and targeted molecular therapy for pancreatic carcinoma19. Recent progresses in Stem cell therapy for pancreatic carcinoma20. Recent progresses in Targeted molecular therapy for pancreatic carcinoma21. Recent progresses in Immunotherapy for pancreatic carcinomaPart Six Combined Interventional Therapy for pancreatic carcinoma22. Interventional Therapy combined with intravenous chemotherapy pancreatic carcinoma23. Interventional Therapy Combined with Radiotherapy for pancreatic carcinoma24. Combined Interventional and Targeted Molecular Therapy for Pancreatic Carcinoma25. Strategies and Methods for Selecting suitable combined Interventional Therapy for Pancreatic Carcinoma26. Recent development and future prospects of Interventional Therapy for Pancreatic Carcinoma